With increasing life expectancies worldwide, providing longitudinal care for patients with neurodegenerative diseases in low-resource settings is a growing challenge.1 According to the 2015 Global Burden of Disease Study, Alzheimer disease, other dementias, and Parkinson disease together affect more than 50 million people globally.2 Furthermore, the WHO estimates that at least 60% of these cases occur in low and middle-income countries.1 Although currently available treatments for neurodegenerative diseases are largely supportive rather than curative, they can reduce morbidity and burden of disease.1 As more effective medications become available and the prevalence of neurodegenerative disease increases, the need for skilled care providers will also increase.
- © 2018 American Academy of Neurology
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.